- Home
- HUDI vs BOLT Comparison
HUDI vs BOLT Comparison
Compare HUDI & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUDI
- BOLT
- Stock Information
- Founded
- HUDI 2018
- BOLT 2015
- Country
- HUDI China
- BOLT United States
- Employees
- HUDI N/A
- BOLT N/A
- Industry
- HUDI Steel/Iron Ore
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- HUDI Industrials
- BOLT Health Care
- Exchange
- HUDI Nasdaq
- BOLT Nasdaq
- Market Cap
- HUDI 18.8M
- BOLT 16.8M
- IPO Year
- HUDI 2021
- BOLT 2021
- Fundamental
- Price
- HUDI $1.49
- BOLT $0.35
- Analyst Decision
- HUDI
- BOLT Hold
- Analyst Count
- HUDI 0
- BOLT 5
- Target Price
- HUDI N/A
- BOLT $1.00
- AVG Volume (30 Days)
- HUDI 13.6K
- BOLT 103.8K
- Earning Date
- HUDI 05-23-2025
- BOLT 05-12-2025
- Dividend Yield
- HUDI N/A
- BOLT N/A
- EPS Growth
- HUDI N/A
- BOLT N/A
- EPS
- HUDI 0.01
- BOLT N/A
- Revenue
- HUDI $74,270,429.00
- BOLT $3,638,000.00
- Revenue This Year
- HUDI N/A
- BOLT N/A
- Revenue Next Year
- HUDI N/A
- BOLT $77.48
- P/E Ratio
- HUDI $156.78
- BOLT N/A
- Revenue Growth
- HUDI N/A
- BOLT N/A
- 52 Week Low
- HUDI $1.27
- BOLT $0.30
- 52 Week High
- HUDI $3.45
- BOLT $1.34
- Technical
- Relative Strength Index (RSI)
- HUDI 55.55
- BOLT 45.53
- Support Level
- HUDI $1.36
- BOLT $0.35
- Resistance Level
- HUDI $1.51
- BOLT $0.38
- Average True Range (ATR)
- HUDI 0.13
- BOLT 0.03
- MACD
- HUDI 0.02
- BOLT 0.00
- Stochastic Oscillator
- HUDI 85.19
- BOLT 29.16
About HUDI Huadi International Group Co. Ltd.
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.